Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole 2% ointment versus vehicle for mild-to-moderate atopic dermatitis
2018-000731-27Phase 3
- Sponsor
- Pfizer
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing Crisaborole topical ointment 2% with Vehicle ointment (2 arms). Primary endpoint: Success in ISGA.
02
Drugs
crisaborole
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2018-000731-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000731-27.